Optical Coherence Tomography: Prognostic Value and Artificial Intelligence — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Optical Coherence Tomography: Prognostic Value and Artificial Intelligence — Stella

Home/Coronary Arterial Disease/

View on ClinicalTrials.gov

Recruiting

Back to Coronary Arterial Disease trials

Trial locations(1 site)

Netherlands

Radboudumc, Nijmegen, Gelderland

Key details

Sponsor

Radboud University Medical Center

Enrollment target

~1,000 participants

Started

November 2021

Primary completion

December 2028

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.